Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Curis Inc CRIS

Sector: Healthcare | Sub-Sector: Biotechnology

Curis, Inc., is a drug discovery and development company. The Company is engaged in the development of its proprietary targeted cancer drug candidates, including CUDC-907, HDAC and phosphatidylinositol-3-kinase, or PI3K.
Price: $1.48 Volume: 148,577
Change: $-0.04 % Change: -2.63%
Day High/Low: 1.52/1.460 52 Week High/Low: 3.65/1.19
Last Traded: November 28, 2014 08:00 Transaction Volume: 200
Open: 1.52 Previous Close: 1.52
Bid: 1.46 Ask:
Bid Size: 100 Ask Size: 0
Market Cap: 127.3m Shares Out: 86.0m
PE Ratio: N/A Dividend Yield: N/A

Latest Bullboard Posts